Viewing StudyNCT00085969



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00085969
Status: COMPLETED
Last Update Posted: 2015-02-23
First Post: 2004-06-18

Brief Title: Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
Lilly View
diabetes View
exenatide View
Amylin View